Clinical Trial Update: Clinical Trial of Sutent to Treat Metastatic Melanoma [Phase 2]

View source ↗

Summary

A status update for a Phase 2 trial evaluating Sutent (sunitinib) in metastatic melanoma; the study sponsored by California Pacific Medical Center Research Inst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: California Pacific Medical Center Research Institute | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED